148 related articles for article (PubMed ID: 11853122)
1. Coadministration of L-NOARG and tiapride: effects on catalepsy in male mice.
Cavas M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):69-73. PubMed ID: 11853122
[TBL] [Abstract][Full Text] [Related]
2. Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration.
Navarro JF; Pedraza C; Martín M; Manzaneque JM; Dávila G; Maldonado E
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):835-44. PubMed ID: 9723123
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery.
Del-Bel EA; Guimarães FS; Joca SR; Echeverry MB; Ferreira FR
J Psychopharmacol; 2010 Mar; 24(3):397-405. PubMed ID: 18838497
[TBL] [Abstract][Full Text] [Related]
4. L-NOARG-induced catalepsy can be influenced by glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus.
Iacopucci AP; Mello RO; Barbosa-Silva R; Melo-Thomas L
Behav Brain Res; 2012 Oct; 234(2):149-54. PubMed ID: 22749845
[TBL] [Abstract][Full Text] [Related]
5. Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice.
Del Bel EA; Guimarães FS
Psychopharmacology (Berl); 2000 Jan; 147(4):356-61. PubMed ID: 10672628
[TBL] [Abstract][Full Text] [Related]
6. L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice.
Marras RA; Martins AP; Del Bel EA; Guimarães FS
Neuroreport; 1995 Dec; 7(1):158-60. PubMed ID: 8742441
[TBL] [Abstract][Full Text] [Related]
7. Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice.
Del Bel EA; Souza AS; Guimarães FS; da-Silva CA; Nucci-da-Silva LP
Psychopharmacology (Berl); 2002 Apr; 161(1):32-7. PubMed ID: 11967628
[TBL] [Abstract][Full Text] [Related]
8. Serotonin modulation of catalepsy induced by N(G)-nitro-L-arginine in mice.
Nucci-da-Silva LP; Guimarães FS; Del Bel EA
Eur J Pharmacol; 1999 Aug; 379(1):47-52. PubMed ID: 10499370
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice.
Fontana L; Souza AS; Del Bel EA; Oliveira RM
Braz J Med Biol Res; 2005 Nov; 38(11):1649-54. PubMed ID: 16258634
[TBL] [Abstract][Full Text] [Related]
10. Catalepsy induced by nitric oxide synthase inhibitors.
Del Bel EA; da Silva CA; Guimarães FS
Gen Pharmacol; 1998 Feb; 30(2):245-8. PubMed ID: 9580128
[TBL] [Abstract][Full Text] [Related]
11. Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats.
Del Bel EA; da Silva CA; Guimarães FS; Bermúdez-Echeverry M
Eur J Pharmacol; 2004 Feb; 485(1-3):175-81. PubMed ID: 14757138
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide in experimental models of psychosis in rats.
Gupta M; Balakrishnan S; Pandhi P
Methods Find Exp Clin Pharmacol; 2001 Nov; 23(9):497-500. PubMed ID: 11876023
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.
Lazzarini M; Salum C; Del Bel EA
Psychopharmacology (Berl); 2005 Aug; 181(1):71-9. PubMed ID: 15806417
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide on motor behavior.
Del Bel EA; Guimarães FS; Bermúdez-Echeverry M; Gomes MZ; Schiaveto-de-souza A; Padovan-Neto FE; Tumas V; Barion-Cavalcanti AP; Lazzarini M; Nucci-da-Silva LP; de Paula-Souza D
Cell Mol Neurobiol; 2005 Mar; 25(2):371-92. PubMed ID: 16047547
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
Gomes FV; Del Bel EA; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
[TBL] [Abstract][Full Text] [Related]
16. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
Erkent U; Iskit AB; Onur R; Ilhan M
Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
18. The influence of the nitric oxide synthase inhibitor L-NOARG on the effects of ethanol in rats after acute ethanol administration.
Vassiljev V; Mesila I; Väli M; Pokk P
Pharmacol Toxicol; 2000 Feb; 86(2):63-7. PubMed ID: 10728916
[TBL] [Abstract][Full Text] [Related]
19. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: potential implication for the treatment of Parkinsonism?
Krzaścik P; Kostowski W
Pol J Pharmacol; 1997 Aug; 49(4):263-6. PubMed ID: 9437770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
